Literature DB >> 28331218

Identification of a novel heterozygous mutation of the Aggrecan gene in a family with idiopathic short stature and multiple intervertebral disc herniation.

Sumito Dateki1, Akiko Nakatomi1, Satoshi Watanabe1,2, Hitomi Shimizu1,2, Yukiko Inoue3, Hideo Baba4, Koh-Ichiro Yoshiura2, Hiroyuki Moriuchi1.   

Abstract

Aggrecan is a critical proteoglycan component of the extracellular matrix of the growth plates and articular cartilage and has a key role in the biophysical and biomechanical properties of cartilage. Recently, heterozygous mutations in the ACAN gene, which encodes aggrecan, have been identified in patients with short stature and accelerated bone age. We herein report another family with a heterozygous ACAN mutation associated with idiopathic short stature along with accelerated bone age and early-onset herniation of the lumbar discs at the levels of L1/2 through L5/S1. Whole-exome sequencing identified a novel heterozygous frameshift mutation in the ACAN gene (c.1744delT; p.Phe582fs*69) in all of the affected family members but not in the unaffected one, providing further evidence that ACAN haploinsufficiency causes short stature with advanced bone maturation. In addition, we advocate early-onset multiple disc herniation as a novel phenotype associated with ACAN haploinsufficiency.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28331218     DOI: 10.1038/jhg.2017.33

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  17 in total

Review 1.  Nonsense-mediated decay approaches the clinic.

Authors:  Jill A Holbrook; Gabriele Neu-Yilik; Matthias W Hentze; Andreas E Kulozik
Journal:  Nat Genet       Date:  2004-08       Impact factor: 38.330

2.  Familial osteochondritis dissecans associated with early osteoarthritis and disproportionate short stature.

Authors:  E-L Stattin; Y Tegner; M Domellöf; N Dahl
Journal:  Osteoarthritis Cartilage       Date:  2008-01-15       Impact factor: 6.576

3.  A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis.

Authors:  Lindsay Gleghorn; Rajkumar Ramesar; Peter Beighton; Gillian Wallis
Journal:  Am J Hum Genet       Date:  2005-07-22       Impact factor: 11.025

4.  Dwarfism and age-associated spinal degeneration of heterozygote cmd mice defective in aggrecan.

Authors:  H Watanabe; K Nakata; K Kimata; I Nakanishi; Y Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

5.  Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene.

Authors:  Jose Bernardo Quintos; Michael H Guo; Andrew Dauber
Journal:  J Pediatr Endocrinol Metab       Date:  2015-07       Impact factor: 1.634

6.  Aggrecan is required for growth plate cytoarchitecture and differentiation.

Authors:  Kristen L Lauing; Mauricio Cortes; Miriam S Domowicz; Judith G Henry; Alexis T Baria; Nancy B Schwartz
Journal:  Dev Biol       Date:  2014-10-18       Impact factor: 3.582

7.  Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature.

Authors:  Sophie R Wang; Christina M Jacobsen; Heather Carmichael; Aaron B Edmund; Jerid W Robinson; Robert C Olney; Timothy C Miller; Jennifer E Moon; Veronica Mericq; Lincoln R Potter; Matthew L Warman; Joel N Hirschhorn; Andrew Dauber
Journal:  Hum Mutat       Date:  2015-03-16       Impact factor: 4.878

8.  Aggrecan modulation of growth plate morphogenesis.

Authors:  Miriam S Domowicz; Mauricio Cortes; Judith G Henry; Nancy B Schwartz
Journal:  Dev Biol       Date:  2009-03-03       Impact factor: 3.582

9.  A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan.

Authors:  Stuart W Tompson; Barry Merriman; Vincent A Funari; Maryline Fresquet; Ralph S Lachman; David L Rimoin; Stanley F Nelson; Michael D Briggs; Daniel H Cohn; Deborah Krakow
Journal:  Am J Hum Genet       Date:  2008-12-24       Impact factor: 11.025

10.  Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations.

Authors:  Alexandra Gkourogianni; Melissa Andrew; Leah Tyzinski; Melissa Crocker; Jessica Douglas; Nancy Dunbar; Jan Fairchild; Mariana F A Funari; Karen E Heath; Alexander A L Jorge; Tracey Kurtzman; Stephen LaFranchi; Seema Lalani; Jan Lebl; Yuezhen Lin; Evan Los; Dorothee Newbern; Catherine Nowak; Micah Olson; Jadranka Popovic; Štepánka Pruhová; Lenka Elblova; Jose Bernardo Quintos; Emma Segerlund; Lucia Sentchordi; Marwan Shinawi; Eva-Lena Stattin; Jonathan Swartz; Ariadna González Del Angel; Sinhué Diaz Cuéllar; Hidekazu Hosono; Pedro A Sanchez-Lara; Vivian Hwa; Jeffrey Baron; Ola Nilsson; Andrew Dauber
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

View more
  18 in total

1.  A balanced reciprocal translocation t(10;15)(q22.3;q26.1) interrupting ACAN gene in a family with proportionate short stature.

Authors:  M Crippa; S Giangiobbe; R Villa; I Bestetti; T De Filippis; L Fatti; J Taurino; L Larizza; L Persani; F Bellini; P Finelli; M T Bonati
Journal:  J Endocrinol Invest       Date:  2018-01-04       Impact factor: 4.256

Review 2.  Growth plate gene involment and isolated short stature.

Authors:  Maria Felicia Faienza; Mariangela Chiarito; Giacomina Brunetti; Gabriele D'Amato
Journal:  Endocrine       Date:  2020-06-05       Impact factor: 3.633

Review 3.  Aggrecan in Cardiovascular Development and Disease.

Authors:  Christopher D Koch; Chan Mi Lee; Suneel S Apte
Journal:  J Histochem Cytochem       Date:  2020-09-01       Impact factor: 2.479

4.  Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature.

Authors:  Nadine N Hauer; Heinrich Sticht; Sangamitra Boppudi; Christian Büttner; Cornelia Kraus; Udo Trautmann; Martin Zenker; Christiane Zweier; Antje Wiesener; Rami Abou Jamra; Dagmar Wieczorek; Jaqueline Kelkel; Anna-Maria Jung; Steffen Uebe; Arif B Ekici; Tilman Rohrer; André Reis; Helmuth-Günther Dörr; Christian T Thiel
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

5.  ACAN mutations as a cause of familial short stature.

Authors:  Sumito Dateki
Journal:  Clin Pediatr Endocrinol       Date:  2017-07-27

6.  Ablation of protein phosphatase 5 (PP5) leads to enhanced both bone and cartilage development in mice.

Authors:  Jun Wang; Yong Cao; Bin Qiu; Jianyong Du; Tingting Wang; Chao Wang; Ran Deng; Xudong Shi; Kai Gao; Zhongwen Xie; Weidong Yong
Journal:  Cell Death Dis       Date:  2018-02-12       Impact factor: 8.469

7.  High frequency of pathogenic ACAN variants including an intragenic deletion in selected individuals with short stature.

Authors:  L Stavber; T Hovnik; P Kotnik; L Lovrečić; J Kovač; T Tesovnik; S Bertok; K Dovč; M Debeljak; T Battelino; M Avbelj Stefanija
Journal:  Eur J Endocrinol       Date:  2020-03       Impact factor: 6.664

Review 8.  Novel genetic cause of idiopathic short stature.

Authors:  Min Jae Kang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-09-28

9.  Novel aggrecan variant, p. Gln2364Pro, causes severe familial nonsyndromic adult short stature and poor growth hormone response in Chinese children.

Authors:  Dandan Xu; Chengjun Sun; Zeyi Zhou; Bingbing Wu; Lin Yang; Zhuo Chang; Miaoying Zhang; Li Xi; Ruoqian Cheng; Jinwen Ni; Feihong Luo
Journal:  BMC Med Genet       Date:  2018-05-16       Impact factor: 2.103

10.  GHR gene transcript heterogeneity may explain phenotypic variability in GHR pseudoexon (6Ψ) patients.

Authors:  Sumana Chatterjee; Emily Cottrell; Stephen J Rose; Talat Mushtaq; Avinash Vickram Maharaj; Jack Williams; Martin O Savage; Louise A Metherell; Hl Storr
Journal:  Endocr Connect       Date:  2020-02-01       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.